Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

11.34
BATS BZX Real-Time Price
As of 10:36am ET
 +0.23 / +2.07%
Today’s Change
9.16
Today|||52-Week Range
17.53
-26.84%
Year-to-Date

Today’s Trading

Previous close11.11
Today’s open10.94
Day’s range10.88 - 11.47
Volume168,550
Average volume (3 months)1,689,045
Market cap$1.5B
Dividend yield--
Data as of 10:21am ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-39.80%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+34.77%
P/E ratio243.3
Price/Sales9.80
Price/Book40.12

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.34+4.49%
FGENFibroGen Inc+0.12+0.51%
EXELExelixis Inc+0.16+2.88%
LXRXLexicon Pharmaceutic...+0.26+2.15%
Data as of 10:37am ET, 09/04/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers